Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yasushi Yamazoe, Kazumi Ito & Kouichi Yoshinari. (2011) Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order. Drug Metabolism Reviews 43:4, pages 409-439.
Read now
Read now
Grover P Miller. (2008) Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective. Expert Opinion on Drug Metabolism & Toxicology 4:8, pages 1053-1064.
Read now
Read now
Jose M Jimenez-Lopez & Arthur I Cederbaum. (2005) CYP2E1-dependent oxidative stress and toxicity: role in ethanol-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 1:4, pages 671-685.
Read now
Read now
D. F. V. Lewis, M. G. Bird, M. Dickins, B. G. Lake, P. J. Eddershaw, M. H. Tarbit, P. S. Goldfarb. (2000) Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform. Xenobiotica 30:1, pages 1-25.
Read now
Read now
B. C. JONES*C. A. TYMAN & D. A. SMITH. (1997) Identification of the cytochrome P450 isoforms involved in the O-demethylation of 4-nitroanisole in human liver microsomes. Xenobiotica 27:10, pages 1025-1037.
Read now
Read now
Articles from other publishers (19)
Samuel L. Collom, Ryan M. Laddusaw, Amber M. Burch, Petr Kuzmic, Martin D. PerryJr.Jr. & Grover P. Miller. (2008) CYP2E1 Substrate Inhibition. Journal of Biological Chemistry 283:6, pages 3487-3496.
Crossref
Crossref
Jack Uetrecht & William Trager. 2007. Drug Metabolism. Drug Metabolism
33
108
.
I. M. Danko & N. A. Chaschin. (2007) Structure-functional characterization of cytochrome P4502E1 (CYP2E1). Biopolymers and Cell 23:2, pages 67-85.
Crossref
Crossref
Samuel L. Collom, Arvind P. Jamakhandi, Alan J. Tackett, Anna Radominska-Pandya & Grover P. Miller. (2007) CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling. Archives of Biochemistry and Biophysics 459:1, pages 59-69.
Crossref
Crossref
Yong Wang, Chuanlu Yang , Hongming Wang, Keli Han & Sason Shaik. (2007) A New Mechanism for Ethanol Oxidation Mediated by Cytochrome P450 2E1: Bulk Polarity of the Active Site Makes a Difference. ChemBioChem 8:3, pages 277-281.
Crossref
Crossref
Anna L. Blobaum. (2006) MECHANISM-BASED INACTIVATION AND REVERSIBILITY: IS THERE A NEW TREND IN THE INACTIVATION OF CYTOCHROME P450 ENZYMES?. Drug Metabolism and Disposition 34:1, pages 1-7.
Crossref
Crossref
Destiny M. Davenport & Michael J. Wargovich. (2005) Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic. Food and Chemical Toxicology 43:12, pages 1753-1762.
Crossref
Crossref
Carol A. Kemp, Jean-Didier Maréchal & Michael J. Sutcliffe. (2005) Progress in cytochrome P450 active site modeling. Archives of Biochemistry and Biophysics 433:2, pages 361-368.
Crossref
Crossref
F. Peter Guengerich. 2005. Cytochrome P450. Cytochrome P450
377
530
.
Brad Reisfeld & Raymond S.H. Yang. (2004) A reaction network model for CYP2E1-mediated metabolism of toxicant mixtures. Environmental Toxicology and Pharmacology 18:2, pages 173-179.
Crossref
Crossref
A. L. Blobaum. (2004) Novel Reversible Inactivation of Cytochrome P450 2E1 T303A by tert-Butyl Acetylene: The Role of Threonine 303 in Proton Delivery to the Active Site of Cytochrome P450 2E1. Journal of Pharmacology and Experimental Therapeutics 310:1, pages 281-290.
Crossref
Crossref
D.F.V Lewis, B.G Lake, M.G Bird, G.D Loizou, M Dickins & P.S Goldfarb. (2003) Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme–substrate and enzyme–inhibitor interactions. Toxicology in Vitro 17:1, pages 93-105.
Crossref
Crossref
Stewart B Kirton, Carol A Baxter & Michael J Sutcliffe. (2002) Comparative modelling of cytochromes P450. Advanced Drug Delivery Reviews 54:3, pages 385-406.
Crossref
Crossref
David Lewis. 2001. Guide to Cytochromes P450. Guide to Cytochromes P450
164
210
.
Rosa L. Moreno, Theunis Goosen, Ute M. Kent, Fung-Lung Chung & Paul F. Hollenberg. (2001) Differential Effects of Naturally Occurring Isothiocyanates on the Activities of Cytochrome P450 2E1 and the Mutant P450 2E1 T303A. Archives of Biochemistry and Biophysics 391:1, pages 99-110.
Crossref
Crossref
F Adas, F Berthou, J.P Salaün, Y Dréano & Y Amet. (1999) Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A. Toxicology Letters 110:1-2, pages 43-55.
Crossref
Crossref
Renke Dai, Suoping Zhai, Xiaoxiong Wei, Matthew R. Pincus, Robert E. Vestal & Fred K. Friedman. (1998) Inhibition of human cytochrome P450 1A2 by flavones: A molecular modeling study. Journal of Protein Chemistry 17:7, pages 643-650.
Crossref
Crossref
Fadi Adas, François Berthou, Daniel Picart, Patrick Lozac'h, Françoise Beaugé & Yolande Amet. (1998) Involvement of cytochrome P450 2E1 in the (ω–1)-hydroxylation of oleic acid in human and rat liver microsomes. Journal of Lipid Research 39:6, pages 1210-1219.
Crossref
Crossref
F.Peter Guengerich. (1997) Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chemico-Biological Interactions 106:3, pages 161-182.
Crossref
Crossref